MedPath

Evaluation of a Project to Distribute Water Filters and Cook Stoves in Western Rwanda--Phase 1B

Completed
Conditions
Focus of Study is to Assess Filter and Stove Use and Efficacy in Reducing Exposure to Waterborne and Airborne Pathogens
Registration Number
NCT01998282
Lead Sponsor
London School of Hygiene and Tropical Medicine
Brief Summary

DelAgua Health and Development, Manna Energy and the Rwanda Ministry of Health are collaborating on a project financed by carbon credits that will distribute household-based water filters and high-efficiency cook stoves to approximately 600,000 households in Rwanda. Prior to the full roll out of the campaign, the implementers are conducting research in connection with a distribution among 2000 households in western Rwanda. The objective of this matched cohort study (Phase 1B)are to investigate whether the filters and stoves delivered in October 2012 are still performing and in use, to determine whether they are associated with reductions in exposure to pathogens from drinking water and stoves, and to assembly information on health and other conditions necessary for the design of a large scale health impact evaluation.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
1035
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Personal exposure to PM2.5 and CO (mg/m3)10 months

PM2.5 and CO concentrations will be measure in mg/m3 and reported as the mean concentration over 48 hours.

Secondary Outcome Measures
NameTimeMethod
Thermotolerant coliforms (TTC) in colony forming units (CFU) per 100ml of sample water10 months

TTC will be measured as the total number of colony forming units (CFU) of TTC in the water sample and will be reported as number of CFU per 100ml of sample water.

Trial Locations

Locations (1)

DelAgua Health Rwanda

🇷🇼

Kigali, PO Box 1594, Rwanda

© Copyright 2025. All Rights Reserved by MedPath